Market research
600216.SHG Zhejiang Medicine Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 12B
- P/E ratio
- 14.68
- Analyst target
- 17
- Dividend yield
- 2.1%
- Beta
- 0.32
Community
Investor discussion
1 comment
Sign in to join the 600216.SHG discussion.
5 years, 5 months ago
Zhejiang Medicine Co., Ltd is currently in a long term uptrend where the price is trading 1.4% above its 200 day moving average.
From a valuation standpoint, the stock is 80.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
Zhejiang Medicine Co., Ltd's total revenue rose by 9.6% to $2B since the same quarter in the previous year.
Its net income has increased by 144.0% to $193M since the same quarter in the previous year.
Finally, its free cash flow fell by 28.5% to $83M since the same quarter in the previous year.
Based on the above factors, Zhejiang Medicine Co., Ltd gets an overall score of 4/5.